SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 183 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.

Quarter-by-quarter ownership
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$1,000
-80.0%
12
-92.4%
0.00%
-100.0%
Q1 2018$5,000
-28.6%
1580.0%0.00%
-50.0%
Q4 2017$7,000
+16.7%
1580.0%0.00%0.0%
Q3 2017$6,000
-25.0%
1580.0%0.00%
-33.3%
Q2 2017$8,0001580.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Key Colony Management, LLC 134,600$13,045,00011.31%
Biondo Investment Advisors, LLC 279,717$27,110,0008.33%
GILDER GAGNON HOWE & CO LLC 3,177,130$307,927,0004.48%
DARUMA CAPITAL MANAGEMENT LLC 814,470$78,938,0003.47%
MAGEE THOMSON INVESTMENT PARTNERS LLC 126,022$12,214,0003.01%
NEXT CENTURY GROWTH INVESTORS LLC 768,396$74,472,0002.63%
MARXE AUSTIN W & GREENHOUSE DAVID M 180,000$17,446,0002.38%
Lisanti Capital Growth, LLC 48,280$4,679,0002.35%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 79,017$7,658,0002.00%
Atika Capital Management LLC 21,500$2,084,0001.60%
View complete list of PACIRA PHARMACEUTICALS INC shareholders